Bausch Stroebel

Bausch Stroebel

End-to-end pharmaceutical production systems provider

Overview

Bausch Ströbel partners with pharmaceutical manufacturers to provide end-to-end production solutions. Its offerings include filling and closing machines, containment systems, and secondary packaging, which are combined into integrated production lines that cover the full product lifecycle. The machines and systems work together to safely and efficiently fill, seal, and protect medicines and vaccines, while also handling final packaging. The company differentiates itself through its long history as a family-owned business, a global service network, and a close collaboration with major pharmaceutical companies to deliver fully integrated, lifecycle-oriented solutions. Its goal is to help ensure that essential medicines and vaccines are safely, reliably, and affordably available worldwide by delivering dependable equipment, ongoing service, and comprehensive support.

About Bausch Stroebel

Simplify's Rating
Why Bausch Stroebel is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Industrial & Manufacturing

Healthcare

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Ilshofen, Germany

Founded

1967

Get referred to Bausch Stroebel

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Bausch+Ströbel reported 470 million euro turnover and about 3,000 employees in 2025.
  • The April 2026 rapid.tech 3D Excellence Award strengthens its engineering credibility.
  • Its September 2026 Suzhou event and China push show continued international investment.

What critics are saying

  • Interpack 2026 exposes Bausch+Ströbel to fierce competition from larger packaging rivals.
  • The February 2026 board reset signals strategic pressure and imminent personnel decisions.
  • China expansion raises execution risk if local demand softens in 2026.

What makes Bausch Stroebel unique

  • Bausch+Ströbel pairs filling, containment, and line control in integrated pharma systems.
  • Its 2026 supervisory board adds pharma, mechanical, and strategy expertise.
  • The company touts additive manufacturing for safer, more efficient components.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Life Insurance

401(k) Company Match

Paid Holidays

Paid Vacation

Company News

Rieckermann
Sep 9th, 2025
RIECKERMANN AT ISPE SINGAPORE 2025

Rieckermann, together with their group member Traque and esteemed industry partners Bausch+Stroebel and Harro Höfliger, proudly participated in the ISPE Conference & Exhibition 2025.

Rieckermann
Oct 2nd, 2024
RIECKERMANN MAKES SECOND APPEARANCE AT THE ISPE SINGAPORE 2024

For the second time, Rieckermann, in collaboration with industry partner Bausch+Ströbel, participated in the ISPE Singapore Affiliate Conference & Exhibition 2024.

Recently Posted Jobs

Sign up to get curated job recommendations

Bausch Stroebel is Hiring for 2 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →